2025 Co-Chairs
2025 Advisory Board
The Advisory Board brings a wealth of knowledge and experience on key trends and timely themes to address each year, while leveraging their networks to recruit the leaders and drivers of oncology innovation to ensure that each year’s summit will be an unparalleled success with innovative talks, thought-provoking leadership and a diverse audience of attendees and innovators.
Mara Aspinall
Partner
Illumina Ventures
Polly Brown
Vice President, Head of Business Development, Oncology R&D
AstraZeneca
Derek DiRocco
Partner
RA Capital Management
Gregory Grunberg, MD, MBA
Head, Life Sciences (North America)
Temasek
Manoja Lecamwasam, PhD
System Vice President, Intellectual Property and Life Sciences Innovation
CommonSpirit Health
Melissa McCracken, PhD
Partner
Nextech Ventures LLC
Marie-Claire Peakman, MRPharmS, PhD
Partner, Pfizer Ventures; Executive Director, Worldwide Business Development
Pfizer
Michal Preminger, PhD, MBA
Former Regional Head,
East North America
Johnson & Johnson Innovation LLC
Victoria Richon, PhD
CEO
Entact Bio
Maya R. Said, ScD
Founder and CEO
Outcomes4Me
Ajit Singh, PhD
CEO
Harbinger Health
Dave Stevenson
Managing Director
Merck Global Health Innovation Fund
Darshana Zaveri
Founder and Managing Partner
Catalyst Health Ventures